Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study von Jansen-Landheer, M.L.E.A, Krijnen, P, Oostindiër, M.J, Kloosterman-Boele, W.M, Noordijk, E.M, Nooij, M.A, Steup, W.H, Taminiau, A.H.M, Vree, R, Hogendoorn, P.C.W, Tollenaar, R.A.E.M, Gelderblom, H

Volltext

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials von Whelan, J.S., Jinks, R.C., McTiernan, A., Sydes, M.R., Hook, J.M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I.J., Nooij, M.A., van Glabbeke, M., Grimer, R.J., Hogendoorn, P.C.W., Taminiau, A.H.M., Gelderblom, H.

Volltext

Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergrou... von Nooij, M.A., Whelan, J., Bramwell, V.H.C., Taminiau, A.T., Cannon, S., Hogendoorn, P.C.W., Pringle, J., Uscinska, B.M., Weeden, S., Kirkpatrick, A., Glabbeke, M.v., Craft, A.W.

Volltext

8056 Results of chemotherapy with etoposide, methotrexate, cyclophosphamide, actinomycine D and cisplatin (EMCAP) chemotherapy for high risk gestational trophoblastic neoplasia, a... von Ottevanger, P.B, Blanken, E.A, Groenewoud, J.M.M, van Hoesel, Q, Westermann, A.M, van Driel, W.J, van de Burg, M.E.L, Nooij, M.A, Verheijen, R.H.M

Volltext

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer von Rodenhuis, S., Bontenbal, M., van Hoesel, Q.G.C.M., Smit, W.M., Nooij, M.A., Voest, E.E., van der Wall, E., Hupperets, P., van Tinteren, H., Peterse, J.L., van de Vijver, M.J., de Vries, E.G.E.

Volltext

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients: clinical outcomes and oncologists’ preferences von Nooij, M.A, de Haes, J.C.J.M, Beex, L.V.A.M, Wildiers, J, Klijn, J, Becquart, D, Jassem, J, Engelsman, E, Duchateau, L

Volltext

Stability of patients' preferences for chemotherapy: the impact of experience von Jansen, S J, Kievit, J, Nooij, M A, Stiggelbout, A M

Volltext

Survival of patients with ovarian cancer due to a mismatch repair defect von Crijnen, Th E M, Janssen-Heijnen, M L G, Gelderblom, H, Morreau, J, Nooij, M A, Kenter, G G, Vasen, H F A

Volltext

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients von Nieboer, P, de Vries, E G E, Mulder, N H, Rodenhuis, S, Bontenbal, M, van der Wall, E, van Hoesel, Q G, Smit, W M, Hupperets, P, Voest, E E, Nooij, M A, Boezen, H M, van der Graaf, W T A

Volltext

Bleomycin, Methotrexate, and CCNU in Locally Advanced or Recurrent, Inoperable, Squamous-Cell Carcinoma of the Vulva: An EORTC Gynaecological Cancer Cooperative Group Study von Wagenaar, H.C., Colombo, N., Vergote, I., Hoctin-Boes, G., Zanetta, G., Pecorelli, S., Lacave, A.J., van Hoesel, Q., Cervantes, A., Bolis, G., Namer, M., Lhommé, C., Guastalla, J.P., Nooij, M.A., Poveda, A., Scotto di Palumbo, V., Vermorken, J.B.

Volltext

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients von Nooij, M.A, de Haes, J.C.J.M, Beex, L.V.A.M, Wildiers, J, Klijn, J, Becquart, D, Jassem, J, Engelsman, E, Duchateau, L

Volltext

High-dose chemotherapy in breast cancer. The Dutch trial von de Vries, E.G.E., Bontendal, M., Beex, L.V.A.M., van der Wall, E., Richel, D.J., Nooij, M.A., Voest, E., Hupperets, P., Westermann, A.M., Dalesio, O., Rodenhuis, S.

Volltext

CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study von Nooij, M.A., Steenland, E., Beex, L.V.A.M., van de Bos, B., Ruiter, L., Haes, J.C.J.M.

Volltext

Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the Eur... von McTiernan, A., Jinks, R.C., Sydes, M.R., Uscinska, B., Hook, J.M., Glabbeke, M. van, Bramwell, V., Lewis, I.J., Taminiau, A.H.M., Nooij, M.A., Hogendoorn, P.C.W., Gelderblom, H., Whelan, J.S.

Volltext bestellen

Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials von Whelan, J.S., Jinks, R.C., McTiernan, A., Sydes, M.R., Hook, J.M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I.J., Nooij, M.A., Glabbeke, M. van, Grimer, R.J., Hogendoorn, P.C.W., Taminiau, A.H.M., Gelderblom, H.

Volltext bestellen

“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)... von Engelsman, E., Klijn, J.C.M., Rubens, R.D., Wildiers, J., Beex, L.V.A.M., Nooij, M.A., Rotmensz, N., Sylvester, R.

Volltext

“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer von Engelsman, E., Klijn, J.C.M., Rubens, R.D., Wildiers, J., Beex, L.V.A.M., Nooij, M.A., Rotmensz, N., Sylvester, R.

Volltext

Tumour-free margins in vulvar squamous cell carcinoma: Does distance really matter? von Nooij, L.S, van der Slot, M.A, Dekkers, O.M, Stijnen, T, Gaarenstroom, K.N, Creutzberg, C.L, Smit, V.T.H.B.M, Bosse, T, van Poelgeest, M.I.E

Volltext

Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice von Boer, Florine L., ten Eikelder, Mieke L.G., van Geloven, Nan, Kapiteijn, Ellen H., Gaarenstroom, Katja N., Hughes, Geoff, Nooij, Linda S., Jozwiak, Marta, Tjiong, Ming Y., de Hullu, Joanne M.A., Galaal, Khadra, van Poelgeest, Mariette I.E.

Volltext

Colibactin mutational signatures in NTHL1 tumor syndrome and MUTYH associated polyposis patients von Terlouw, D., Boot, A., Ducarmon, Q.R., Nooij, S., Jessurun, M.A., Leerdam, M.E. van, Tops, C.M., Langers, A.M.J., Morreau, H., Wezel, T. van, Nielsen, M.

Volltext bestellen